KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 126 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q1 2015. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $35,000 | -25.5% | 468 | -24.5% | 0.00% | – |
| Q2 2015 | $47,000 | +104.3% | 620 | +37.8% | 0.00% | – |
| Q1 2015 | $23,000 | +43.8% | 450 | 0.0% | 0.00% | – |
| Q4 2014 | $16,000 | +23.1% | 450 | +10.8% | 0.00% | – |
| Q3 2014 | $13,000 | -18.8% | 406 | 0.0% | 0.00% | – |
| Q2 2014 | $16,000 | +45.5% | 406 | +48.2% | 0.00% | – |
| Q1 2014 | $11,000 | +10.0% | 274 | 0.0% | 0.00% | – |
| Q4 2013 | $10,000 | -16.7% | 274 | 0.0% | 0.00% | – |
| Q3 2013 | $12,000 | +71.4% | 274 | 0.0% | 0.00% | – |
| Q2 2013 | $7,000 | – | 274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 900,559 | $33,636,000 | 3.14% |
| Redmile Group, LLC | 557,761 | $20,777,000 | 2.56% |
| SENZAR ASSET MANAGEMENT, LLC | 79,000 | $2,951,000 | 2.41% |
| Aureus Asset Management, LLC | 134,465 | $5,022,000 | 1.36% |
| REGENTATLANTIC CAPITAL LLC | 193,454 | $7,226,000 | 0.70% |
| PFM Health Sciences, LP | 831,840 | $31,069,000 | 0.62% |
| EAM Investors, LLC | 55,201 | $2,056,000 | 0.37% |
| Dynamic Technology Lab Private Ltd | 5,560 | $207,000 | 0.34% |
| Polar Capital LLP | 350,000 | $13,038,000 | 0.31% |
| Old West Investment Management, LLC | 10,773 | $402,000 | 0.24% |